Eocene Ltd Shs Par $1.80 (New) fell 20.4% on Thursday, November 19, 2026, on 40,454 shares, 2.2 times its average daily volume. No headline about EOCN came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Eocene Ltd Shs Par $1.80 (New) (EOCN:NASDAQ) closed at $1.78 on November 20, 2026, up 1.73% on the day. The stock trades 82.3% below its 52-week high of $10.08 and 1.7% above its 52-week low of $1.75. Over the past year, it lost 73.8%. Eocene Ltd Shs Par $1.80 (New) is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, EOCN closed higher on 105 days (42%). Its best day was April 9, 2026 (+26.21%) and its worst was June 8, 2026 (-32.61%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 5 times.
EoCene Ltd. (NASDAQ: EOCN) is a GI-focused medtech and biopharmaceutical company headquartered in Ramat Gan, Israel, dedicated to advancing innovative solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. The Company is building a diversified platform that combines medical devices, therapeutics and enabling technologies to address significant unmet clinical needs and improve patient outcomes. EoCene's wholly owned subsidiary, Colospan Ltd., is a commercial-stage medical device company developing solutions designed to transform postoperative colorectal care. Its flagship product, CG-100, is an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas, offering a less invasive alternative to current surgical practice.
Find more stocks like EOCN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.